ReviewCancers2026

STAS More than a Prognostic Marker-An Evolving Factor in Operative and Adjuvant Treatment Decisions in Early-Stage NSCLC.

Joshua R Brady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.